Larry M Glasscock

Title: Larry M Glasscock: Innovator in Continuous Flow Analysis Systems

Introduction

Larry M Glasscock is a notable inventor based in Cullman, Alabama. He has made significant contributions to the field of medical diagnostics through his innovative work. His expertise lies in developing systems that enhance the analysis of blood samples, particularly in measuring cholesterol distribution.

Latest Patents

Larry M Glasscock holds a patent for a Controlled Dispersion Flow Analysis System. This continuous flow analysis system is designed to measure the cholesterol distribution among different lipoprotein classes in a blood sample. The process involves separating a blood plasma sample into various lipoprotein classes using single vertical spin density gradient ultracentrifugation. The sample is then introduced into a continuously flowing reagent stream that passes through a detector. A sensor detects the end of the sample in the stream before it enters the reagent stream. In response to this detection, a wash solution is introduced to cleanse any residue or air bubbles from the sample stream. After a predetermined time, the sample stream is closed, and the process is repeated for the next sample. This innovative approach enhances the accuracy and efficiency of cholesterol measurement in clinical settings.

Career Highlights

Throughout his career, Larry has demonstrated a commitment to advancing medical technology. His work has not only contributed to scientific knowledge but has also had practical applications in healthcare. His patent reflects his dedication to improving diagnostic methods and patient care.

Collaborations

Larry has collaborated with several professionals in his field, including Alice Glasscock and Krishnaji R Kulkarni. These collaborations have likely enriched his work and contributed to the development of his innovative systems.

Conclusion

Larry M Glasscock is a distinguished inventor whose work in continuous flow analysis systems has made a significant impact on medical diagnostics. His patented technology represents a crucial advancement in the measurement of cholesterol distribution, showcasing his dedication to improving healthcare solutions.